http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012164732-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_155ecba795cfc880c48ed21eb0378963 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b805f4e227fdf04bee025eedd33122a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5afe759d9ff07a0f9e55f4addc90c28e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_411075be438c72b29efe1ff81a543756 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2509-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 |
| filingDate | 2010-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecd6d083b0507f1417c0836d4fb6ce03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a82f58df8e8d1b1358472dfcaf6646a |
| publicationDate | 2012-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2012164732-A1 |
| titleOfInvention | Cancer tissue-derived cell mass and a process for preparing same |
| abstract | Disclosed is a novel cell mass derived from a cancer tissue, which can reflect the in vivo behavior of a cancer cell correctly. Also disclosed is a process for preparing the cell mass. Specifically disclosed is a cell mass derived from a cancer tissue, which is an separated product that is isolated from a cancer tissue obtained from an individual as a mass containing at least three cancer cells or a cultured product of the separated product and which can retain a proliferation ability in vitro. The cell mass derived from a cancer tissue is produced by, for example, a preparation process comprising the steps of: treating a pulverized product of a cancer tissue removed from a living body with an enzyme; and selecting and collecting a mass containing at least three cancer cells among from an enzymatic treatment product. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3954764-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8841125-B2 |
| priorityDate | 2009-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 260.